National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

PAPERBACK
price:$59.75
add to cart

Rights & Permissions

topleft topright

Medicare: New Directions in Quality Assurance Proceedings (1991)
Institute of Medicine (IOM)

Citation Manager

. "8. A Response." Medicare: New Directions in Quality Assurance Proceedings. Washington, DC: The National Academies Press, 1991.

Please select a format:

BibTeX EndNote RefMan


Page
58
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Medicare: New Directions in Quality Assurance

role in decisions that affect them personally; they are also likely to be willing to challenge traditional authority figures.

SUMMARY

Realization of greater patient involvement in the decisionmaking process, a vision that the IOM and AARP share, holds much promise for fulfilling beneficiaries' hopes and meeting their needs. We look forward to working with the IOM, Congress, the administration, and the provider and beneficiary communities to achieve that end.

REFERENCES

Institute of Medicine. Medicare: A Strategy for Quality Assurance. Volumes I and II. Lohr, K.N., ed. Washington, D.C.: National Academy Press, 1990.


Wennberg, J.E. A Patient Outcomes Orientation: A Response. Pp. 73-78 in Medicare: New Directions in Quality Assurance. Donaldson, M.S., Harris-Wehling, J., and Lohr, K.N., eds. Washington, D.C.: National Academy Press, 1991.

Page
58
Front Matter (R1-R10)
Part 1: Introduction (1-2)
1. Introduction (3-6)
2. The Institute of Medicine Report (7-14)
Part 2: New Directions: More Professionalism, Less Regulation (15-17)
3. The Committee View (18-21)
4. A Response (22-26)
Part 3: New Directions: Organization- and System-Focused Quality Improvement (27-30)
5. The Committee View (31-36)
6. A Response (37-44)
Part 4: New Directions: Improved Decision-Making by Patients and Clinicians (45-47)
7. The Committee View (48-53)
8. A Response (54-58)
Part 5: New Directions: A Patient Outcomes Orientation (59-62)
9. The Committee View (63-72)
10. A Response (73-78)
Part 6: New Directions: Public Accountability and Program Evaluation (79-81)
11. The Committee View (82-85)
12. A Response (86-90)
Part 7: Confronting Special Implementation Issues (91-95)
13. The Epidemiology of Quality Problems (96-104)
14. Legal Concerns (105-115)
15. Translating the Institute of Medicine Report (116-126)
Part 8: New Directions: The Research, Training, and Capacity Building Agendas (127-129)
16. Research and Capacity Building: Issues Raised by the Institute of Medicine Report (130-139)
17. The Research Agenda: An Outside View (140-144)
18. The Training and Capacity Building Agendas: An Outside View (145-150)
Part 9: Response to the Institute of Medicine Report Recommendations (151-154)
19. A Legislator's Response to the Institute of Medicine Report (155-160)
20. A Legislator's Response to the Institute of Medicine Report (161-166)
21. A Physician's Response to the Institute of Medicine Report (167-173)
22. An Administration Response to the Institute of Medicine Report from the Agency for Health Care Policy and Research (174-178)
23. An Administration Response to the Institute of Medicine Report from the Health Care Financing Administration (179-185)
24. A Peer Review Organization Response to the Institute of Medicine Report (186-190)
Part 10: Where Do We Go From Here? (191-193)
25. Where Do We Go From Here? (194-197)
26. Where Do We Go From Here? (198-204)
List of Authors (205-208)